Company profile
Sunset Island Group, Inc.
OTC: SIGO · Healthcare · Drug Manufacturers - Specialty & Generic
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 23
v0.1 · 5/100 weight · pillars only
↑ Piotroski F, listing tenure · ↓ filing timeliness, market scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$690.7k
Employees
6
as of 2026-08-31
Market cap
$592
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$690.7k-$690.7k2017
Operating income-$690.7k-$690.7k2017
Total assets$38.7k$38.7k2017
Liabilities$404.9k$404.9k2017
Equity-$366.3k-$366.3k2017
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Sunset Island Group, Inc.’s financial profile?
Sunset Island Group, Inc. earned -$690.7k in FY2017 net income.
Peers · Healthcare
FusionPharm, Inc.——Virpax Pharmaceuticals, Inc.——HLK Biotech Holding Group, Inc.——AXM Pharma, Inc.——Ormand Industries Inc——Hear AtLast Holdings, Inc.——Neighbors
Orange →Key facts
CEOValerie Baugher
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersSan Clemente, CA
ExchangeOTC: SIGO
Employees6
IPO date2017-02-02
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.